FFCP PHASE1:Mm9::chr2:120276468..120276479,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=76051|HGNC=|MCL_coexpression_id=194|UniProt=|association_with_transcript=-173bp_to_uc008lvw.1_5end|description=CAGE_peak_13_at_Ganc_5end|id=chr2:120276468..120276479,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005795!3.76e-23!4;UBERON:0000995!3.76e-23!4;UBERON:0000474!8.42e-23!9;UBERON:0003100!1.34e-18!11;UBERON:0003975!1.39e-18!5;UBERON:0003134!6.36e-18!8;UBERON:0004175!1.37e-15!9;UBERON:0001987!2.02e-12!2;UBERON:0003124!2.02e-12!2;UBERON:0004340!2.02e-12!2;UBERON:0005156!3.80e-10!26;UBERON:0000990!3.80e-10!26;UBERON:0005631!1.42e-08!3;UBERON:0000478!1.42e-08!3;UBERON:0000158!1.42e-08!3;UBERON:0003133!3.86e-08!24;UBERON:0000993!2.75e-07!1;UBERON:0006834!7.89e-07!1|ontology_enrichment_uberon_v019_2=UBERON:0000993,2.74e-44,1;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0005795,4.02e-12,4;UBERON:0000995,4.02e-12,4;UBERON:0003975,5.59e-10,5;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26;UBERON:0003134,9.78e-07,8|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.125666591329675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173824320192276,0,0,0,0.101839363850316,0,0,0,0,0,0,0,0.0680364991513279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.425820255624806,0,0,13.5275500837479,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177340233642274,0,0,0,0.23467170806371,0.21183207086382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201652370273681,0,0.0962118416403295,0.233753804363138,0,0,0,0,0,0.187682475451182,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p13@Ganc}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:76051 | |||
|HGNC= | |||
|MCL_coexpression_id=194 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=-173bp_to_uc008lvw.1_5end | |||
|cluster_id=chr2:120276468..120276479,+ | |||
|description=CAGE_peak_13_at_Ganc_5end | |||
|id=chr2:120276468..120276479,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005795!3.76e-23!4;UBERON:0000995!3.76e-23!4;UBERON:0000474!8.42e-23!9;UBERON:0003100!1.34e-18!11;UBERON:0003975!1.39e-18!5;UBERON:0003134!6.36e-18!8;UBERON:0004175!1.37e-15!9;UBERON:0001987!2.02e-12!2;UBERON:0003124!2.02e-12!2;UBERON:0004340!2.02e-12!2;UBERON:0005156!3.80e-10!26;UBERON:0000990!3.80e-10!26;UBERON:0005631!1.42e-08!3;UBERON:0000478!1.42e-08!3;UBERON:0000158!1.42e-08!3;UBERON:0003133!3.86e-08!24;UBERON:0000993!2.75e-07!1;UBERON:0006834!7.89e-07!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000993,2.74e-44,1;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0005795,4.02e-12,4;UBERON:0000995,4.02e-12,4;UBERON:0003975,5.59e-10,5;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26;UBERON:0003134,9.78e-07,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.125666591329675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173824320192276,0,0,0,0.101839363850316,0,0,0,0,0,0,0,0.0680364991513279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.425820255624806,0,0,13.5275500837479,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177340233642274,0,0,0,0.23467170806371,0.21183207086382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201652370273681,0,0.0962118416403295,0.233753804363138,0,0,0,0,0,0.187682475451182,1.09890974560359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p13@Ganc | |||
}} |
Revision as of 21:09, 3 August 2015
Short description: | p13@Ganc |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_Ganc_5end |
Coexpression cluster: | MCL_coexpression_mm9:194 |
Association with transcript: | -173bp_to_uc008lvw.1_5end |
EntrezGene: | 76051 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
oviduct | 2.74e-44 | 1 |
female reproductive system | 1.98e-20 | 9 |
female organism | 5.67e-17 | 11 |
embryonic uterus | 4.02e-12 | 4 |
uterus | 4.02e-12 | 4 |
internal female genitalia | 5.59e-10 | 5 |
reproductive structure | 6.33e-08 | 26 |
reproductive system | 6.33e-08 | 26 |
female reproductive organ | 9.78e-07 | 8 |